HR
AZN icon

Hardy Reed’s AstraZeneca AZN Stock Holding History

Hardy Reed’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$493K Buy
2,502
+601
+32% +$116K 0.04% 145
2025
Q4 		$349K Buy
1,901
+52
+3% +$9.12K 0.02% 182
2025
Q3 		$284K Buy
1,849
+180
+11% +$27.2K 0.02% 200
2025
Q2 		$233K Buy
1,669
+37
+2% +$5.19K 0.02% 221
2025
Q1 		$240K Buy
1,632
+36
+2% +$5.21K 0.02% 209
2024
Q4 		$209K Buy
1,596
+5
+0.3% +$700 0.02% 240
2024
Q3 		$248K Buy
1,591
+89
+6% +$14.4K 0.02% 213
2024
Q2 		$234K Buy
+1,502
New +$226K 0.02% 207

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Hardy Reed's AZN Position: Q1 2026 in Review

Hardy Reed increased its AstraZeneca (AZN) stake by 32% in Q1 2026, buying an estimated $116K and bringing the position to 2,502 shares worth $493K. The position accounts for 0.04% of the portfolio, ranked #145.

Hardy Reed first reported a position in AZN in Q2 2024 and has held it in 8 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Hardy Reed held 2,502 shares of AstraZeneca worth $493K as of Q1 2026.
  • Hardy Reed bought 601 AstraZeneca shares in Q1 2026, an estimated $116K.
  • AstraZeneca made up 0.04% of Hardy Reed's portfolio in Q1 2026, its #145 holding.
  • Hardy Reed first reported a position in AstraZeneca in Q2 2024 and has held it in 8 quarters since.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Hardy Reed's 13F filing for Q1 2026, filed 28 Apr 2026.